Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia

被引:135
作者
Jacobs, Victoria [1 ]
Wolter, Scott C. [1 ]
Stevens, Scott [1 ]
May, Heidi T. [1 ]
Bair, Tami L. [1 ]
Anderson, Jeffrey L. [1 ]
Crandall, Brian G. [1 ]
Day, John D. [1 ]
Johanning, Katie [1 ]
Long, Yenh [1 ]
Mallender, Charles [1 ]
Olson, Jeffrey L. [1 ]
Osborn, Jeffrey S. [1 ]
Weiss, J. Peter [1 ]
Bunch, T. Jared [1 ]
机构
[1] Intermt Heart Inst, Intermt Med Ctr, Murray, UT USA
关键词
Atrial fibrillation; Warfarin; Stroke; Oral anticoagulation; Time in therapeutic range; Dementia; Microembolus; Microbleed; COGNITIVE FUNCTION; STROKE; METAANALYSIS; IMPAIRMENT; COHORT;
D O I
10.1016/j.hrthm.2014.08.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The mechanisms behind the association of atrial fibrillation (AF) and dementia are unknown. One possibility is that exposure to chronic microembolism or microbleeds results in repetitive cerebral injury that is manifest by cognitive decline. OBJECTIVE The purpose of this study was to test the hypothesis that AF patients with a Low percentage of time in the therapeutic range (TTR) are at higher risk for dementia due to under- or overanticoagulation. METHODS Patients anticoagulated with warfarin (target international normalized ratio [INR] 2-3), managed by the Intermountain Healthcare Clinical Pharmacist Anticoagulation Service with no history of dementia or stroke/transient ischemic attack, were included in the study. The primary outcome was dementia incidence defined by ICD-9 codes. Percent time in TTR was calculated using the method of linear interpolation and stratified as >75%, 51%-75%, 26%-50%, and <= 25%. Multivariable Cox hazard regression was used to determine dementia incidence by percentage categories of TTR. RESULTS A total of 2605 patients (age 73.7 +/- 10.8 years, 1408 [54.0%] male) were studied. The CHADS(2) score distribution was 0: 216 (8.3%); 1: 579 (22.2%); 2: 859(33.0%); 3: 708 (27.2%); and >= 4: 243 (9.3%). The percent TTR averaged 63.1 +/- 21.3, with percent INR <2.0: 25.6% +/- 17.9% and percent INR >3.0: 16.2% +/- 13.6%. Dementia was diagnosed in 109 patients (4.2%) (senile: 37 [1.4%]; vascular: 8 [0.3%]; Alzheimer: 64 (2.5%]). After adjustment, decreasing categories of percent TTR were associated with increased dementia risk (vs >75%): <25%: hazard ratio (HR) 5.34, P < .0001; 26%-50%: HR 4.10, P < .0001; and 51%-75%; HR = 2.57, P = .001. CONCLUSION Quality of anticoagulation management represented as percent TTR among AF patients without dementia was associated with dementia incidence. These data support the possibility of chronic cerebral injury as a mechanism that underlies the association of AF and dementia.
引用
收藏
页码:2206 / 2213
页数:8
相关论文
共 23 条
[1]   A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II) [J].
Anderson, Jeffrey L. ;
Horne, Benjamin D. ;
Stevens, Scott M. ;
Woller, Scott C. ;
Samuelson, Kent M. ;
Mansfield, Justin W. ;
Robinson, Michelle ;
Barton, Stephanie ;
Brunisholz, Kim ;
Mower, Chrissa P. ;
Huntinghouse, John A. ;
Rollo, Jeffrey S. ;
Siler, Dustin ;
Bair, Tami L. ;
Knight, Stacey ;
Muhlestein, Joseph B. ;
Carlquist, John F. .
CIRCULATION, 2012, 125 (16) :1997-+
[2]   Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia [J].
Bunch, T. Jared ;
Weiss, J. Peter ;
Crandall, Brian G. ;
May, Heidi T. ;
Bair, Tami L. ;
Osborn, Jeffrey S. ;
Anderson, Jeffrey L. ;
Muhlestein, Joseph B. ;
Horne, Benjamin D. ;
Lappe, Donald L. ;
Day, John D. .
HEART RHYTHM, 2010, 7 (04) :433-437
[3]  
Charidimou Andreas, 2012, Front Neurol, V3, P133
[4]   Atrial fibrillation, stroke, and quality of life [J].
Chinitz, Jason S. ;
Castellano, Jose M. ;
Kovacic, Jason C. ;
Fuster, Valentin .
EVOLVING CHALLENGES IN PROMOTING CARDIOVASCULAR HEALTH, 2012, 1254 :140-150
[5]   Atrial Fibrillation and Risk of Dementia: A Prospective Cohort Study [J].
Dublin, Sascha ;
Anderson, Melissa L. ;
Haneuse, Sebastien J. ;
Heckbert, Susan R. ;
Crane, Paul K. ;
Breitner, John C. S. ;
McCormick, Wayne ;
Bowen, James D. ;
Teri, Linda ;
McCurry, Susan M. ;
Larson, Eric B. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (08) :1369-1375
[6]   SILENT CEREBRAL INFARCTION IN PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION [J].
EZEKOWITZ, MD ;
JAMES, KE ;
NAZARIAN, SM ;
DAVENPORT, J ;
BRODERICK, JP ;
GUPTA, SR ;
THADANI, V ;
MEYER, ML ;
BRIDGERS, SL .
CIRCULATION, 1995, 92 (08) :2178-2182
[7]   Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation [J].
Flaker, Greg C. ;
Pogue, Janice ;
Yusuf, Salim ;
Pfeffer, Marc A. ;
Goldhaber, Samuel Z. ;
Granger, Christopher B. ;
Anand, Inderjit S. ;
Hart, Robert ;
Connolly, Stuart J. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (03) :277-U87
[8]   Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation [J].
Hart, Robert G. ;
Pearce, Lesly A. ;
Aguilar, Maria I. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) :857-867
[9]   An integrated chronic care program for patients with atrial fibrillation Study protocol and methodology for an ongoing prospective randomised controlled trial [J].
Hendriks, Jeroen M. L. ;
de Wit, Rianne ;
Vrijhoef, Hubertus J. M. ;
Tieleman, Robert G. ;
Crijns, Harry J. G. M. .
INTERNATIONAL JOURNAL OF NURSING STUDIES, 2010, 47 (10) :1310-1316
[10]   Cognitive Impairment Associated With Atrial Fibrillation A Meta-analysis [J].
Kalantarian, Shadi ;
Stern, Theodore A. ;
Mansour, Moussa ;
Ruskin, Jeremy N. .
ANNALS OF INTERNAL MEDICINE, 2013, 158 (05) :338-+